Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -739 | -4,251 | -3,076 | -1,578 | -614 |
| Depreciation Amortization | 144 | 651 | 506 | 430 | 244 |
| Accounts receivable | -13 | -10 | -17 | -63 | -25 |
| Accounts payable and accrued liabilities | 8 | 177 | 156 | 185 | 1 |
| Other Working Capital | -296 | 758 | 1,038 | -47 | 216 |
| Other Operating Activity | 576 | 2,275 | 1,213 | 890 | 70 |
| Operating Cash Flow | $-322 | $-400 | $-181 | $-183 | $-108 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1 | -1 | -1 | -1 |
| Purchase Sale Intangibles | N/A | -78 | -67 | -56 | -32 |
| Other Investing Activity | 0 | -78 | -67 | -56 | -32 |
| Investing Cash Flow | $N/A | $-79 | $-68 | $-57 | $-32 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 384 | 400 | 148 | 123 | N/A |
| Other Financing Activity | -30 | -60 | -26 | 0 | 0 |
| Financing Cash Flow | $354 | $339 | $122 | $123 | $N/A |
| Beginning Cash Position | 10 | 150 | 150 | 150 | 150 |
| End Cash Position | 41 | 10 | 22 | 32 | 9 |
| Net Cash Flow | $32 | $-140 | $-128 | $-118 | $-140 |
| Free Cash Flow | |||||
| Operating Cash Flow | -322 | -400 | -181 | -183 | -108 |
| Capital Expenditure | N/A | -1 | -1 | -1 | -1 |
| Free Cash Flow | -322 | -401 | -182 | -184 | -109 |